UBriGene Biosciences collects $20m in Series C-plus financing
The round follows the close of uBriGene’s Series C financing in September 2022.
The round follows the close of uBriGene’s Series C financing in September 2022.
Copyright PEI Media
Not for publication, email or dissemination
